Community Research and Development Information Service - CORDIS

Search projects and results

Results 1 - 10 of 98
Results/page:
12 3 4 5 6 7 8 9 10 > 
Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe
ID: 503216
Start date: 2004-01-01, End date: 2011-02-28
Leukemias are a challenge to society and a cost factor because of their frequency in all age groups. They also serve as a model for a variety of diseases and possess exemplary relevance for basic research and patient care. Leukemia research and therapy have achieved high stand...
Programme: FP6-LIFESCIHEALTH
Record Number: 75278
Last updated on: 2011-04-05
Final Report Summary - GLYFDIS (Glycans in Body Fluids - Potential for Disease Diagnostics)
Developing effective tools to screen for cancer is an important endeavour and there is much research taking place to develop these tools. Cancer is a significant burden on individuals, families and society. The economic impact of cancer is substantial. In 2002, the overall cos...
Programme: FP6-LIFESCIHEALTH
Record Number: 49657
Last updated on: 2011-04-14
Final Report Summary - TAGIP (Targeted gene integration in plants: vectors, mechanisms and applications for protein production)
One of the limitations of current transgenics technologies in plants is that the process of DNA transformation is not precise. There is no control on the location or copy number of transgene insertion, and as a result the transgene is often silenced in unpredictable ways, imme...
Programme: FP6-LIFESCIHEALTH
Record Number: 47050
Last updated on: 2011-04-14
Final Report Summary - PAINGENES (Heritability of chronic neuropathic pain)
Chronic pain undermines the health and welfare of millions of EU citizens and carries with it enormous personal, social and financial costs. A recent large survey estimates that 19% of European adults suffer from one or another chronic pain condition (Breivik et al. 2006). Ind...
Programme: FP6-LIFESCIHEALTH
Record Number: 47902
Last updated on: 2011-04-14
A European Network for Integrated Genome Annotation
ID: 503265
Start date: 2004-01-01, End date: 2009-06-30
The objective of the BIOSAPIENS Network of Excellence is to provide an infrastructure to support a large scale, concerted effort to annotate genome data by laboratories distributed around Europe. This will use both informatics tools and input from experimentalists. Experimenta...
Programme: FP6-LIFESCIHEALTH
Record Number: 75293
Last updated on: 2013-03-26
European Vigilance Network for the Management of Antiviral Drug Resistance
ID: 503359
Start date: 2004-05-01, End date: 2008-10-31
The overall objective of the viRgil Network of Excellence is to set up the first-ever European Vigilance Network capable of addressing current and emerging antiviral drugs resistance developments. Focusing first on three major diseases (influenza and viral hepatitis B and C), ...
Programme: FP6-LIFESCIHEALTH
Record Number: 75304
Last updated on: 2013-03-26
In-Silico Prediction of gene function
ID: 503567
Start date: 2004-03-01, End date: 2008-06-30
The GENEFUN project aims at addressing two important issues. Improving existing sequence-similarity based function annotation tools, and developing and integrating methods that consider information on 3D structure as well as on physical and functional interactions between gene...
Programme: FP6-LIFESCIHEALTH
Record Number: 78713
Last updated on: 2013-03-26
Embryonic stem cells for therapy and exploration of mechanisms in Huntington disease
ID: 37349
Start date: 2006-12-01, End date: 2009-11-30
Embryonic stem cell (ES) lines have potential interest for exploring mechanisms and therapeutics of genetically-determined diseases, due to their fundamental attributes, unlimited expansion and pluripotency: isogenic cells of any phenotype can be produced in any requested amou...
Programme: FP6-LIFESCIHEALTH
Record Number: 84968
Last updated on: 2012-10-19
Programmed cell death across the eukaryotic kingdom
ID: 511983
Start date: 2004-12-01, End date: 2008-05-31
Programmed cell death (PCD) is normally invoked during development and immunity, but inappropriate PCD is associated with pathologies including cancer and degenerative diseases. Conserved genes controlling apoptosis, a type of PCD dependent upon caspase proteinases, were first...
Programme: FP6-LIFESCIHEALTH
Record Number: 74068
Last updated on: 2009-12-14
Reprogramming the immune System for the Establishment of Tolerance
ID: 512090
Start date: 2005-03-01, End date: 2010-08-31
Transplantation dramatically improves the survival of patients with end-stage failure of vital organs. However, as a directconsequence of the immunosuppressive drugs permanently required to prevent rejection, recipients have a significantly increased risk of infection and mali...
Programme: FP6-LIFESCIHEALTH
Record Number: 75691
Last updated on: 2010-10-12
12 3 4 5 6 7 8 9 10 > 
List retrieved on: 2017-07-27
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top